Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumors

Protocol
12-114
Full Title
Treatment of Newly Diagnosed Higher Risk Favorable Histology Wilms Tumor (COG-AREN0533)
Purpose

Surgery, chemotherapy, and/or radiation therapy are routinely used to treat Wilms tumor (a kidney cancer that most commonly occurs in children). However, some treatments can cause side effects later in life. Doctors are therefore seeking effective treatment regimens that have a lower risk of late effects.

In this Children’s Oncology Group study, researchers are determining the best way to treat patients with different types of higher-risk Wilms tumors which had a favorable histology at the time of diagnosis. The goals of the study are to find out:

  • If patients whose tumors spread only to their lungs can avoid radiation therapy to the lungs if the tumors disappear after six weeks of standard chemotherapy
  • If patients with tumor spread in the lungs that did not go away after six weeks of chemotherapy can be treated with two additional chemotherapy drugs, plus radiation therapy to the lungs
  • If patients whose Wilms tumors spread to other parts of the body can be treated with two additional chemotherapy drugs along with the standard drugs and standard radiation therapy
  • If information about missing genetic material (called “loss of heterogeneity”) can be used to determine a patient’s treatment.
Eligibility

To be eligible for this study, patients must meet several criteria, including but not limited to the following:

  • Patients must be newly diagnosed with a kidney tumor.
  • Patients must be under age 30 at the time of diagnosis.

For more information about this study and to inquire about eligibility, please contact Dr. Rachel Kobos at 212-639-8451.

Disease(s)
Kidney Cancer
Locations
Related Diseases